<p>STAAR Surgical（纳斯达克股票代码：STAA - 获取免费报告）的股票在周三发布的报告中被 Weiss Ratings 的股票研究分析师重新评定为 “卖出（d）” 评级，Weiss Ratings 报道。</p>
<p>获取 <strong>STAAR Surgical</strong> 警报：</p>
<ul>
<li>内部人士显著增持的四大股票</li>
</ul>
<p>STAA 已经成为其他多份报告的主题。Piper Sandler 在 6 月 18 日的报告中将 STAAR Surgical 的评级上调至 “持有”。Canaccord Genuity Group 在 8 月 6 日的研究报告中将 STAAR Surgical 的目标价格从 20.00 美元上调至 28.00 美元，并给予该公司 “持有” 评级。Mizuho 在 7 月 16 日的研究报告中将 STAAR Surgical 的目标价格从 17.00 美元上调至 18.00 美元，并给予该公司 “中性” 评级。最后，Stifel Nicolaus 在 8 月 7 日的研究报告中设定了 STAAR Surgical 的目标价格为 28.00 美元，并给予该公司 “持有” 评级。十位研究分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，STAAR Surgical 目前的共识评级为 “减持”，平均目标价格为 20.67 美元。</p>
<p><strong>查看我们对 STAAR Surgical 的最新分析</strong></p>
<h2>STAAR Surgical 股票下跌 0.8%</h2>
<ul>
<li>随着 2024 年美国前景改善，Star Surgical 表现亮眼</li>
</ul>
<p>周三，STAA 的股价开盘为 26.50 美元。STAAR Surgical 的 12 个月低点为 13.50 美元，12 个月高点为 33.28 美元。该公司的 50 日移动平均线为 26.83 美元，200 日移动平均线为 20.79 美元。该股票的市值为 13.1 亿美元，市盈率为-13.73，贝塔值为 0.82。</p>
<h2>机构投资者对 STAAR Surgical 的看法</h2>
<p>大型投资者最近增加或减少了对该公司的持股。CWM LLC 在第二季度将其在 STAAR Surgical 的持股增加了 74.1%。CWM LLC 现在拥有 1,563 股该医疗器械供应商的股票，价值 26,000 美元，此前在上个季度增持了 665 股。US Bancorp DE 在第一季度将其在 STAAR Surgical 的持股增加了 1,693.0%。US Bancorp DE 现在拥有 2,044 股该医疗器械供应商的股票，价值 36,000 美元，此前在上个季度增持了 1,930 股。Brooklyn Investment Group 在第一季度将其在 STAAR Surgical 的持股增加了 1,564.0%。Brooklyn Investment Group 现在拥有 2,679 股该医疗器械供应商的股票，价值 47,000 美元，此前在上个季度增持了 2,518 股。GAMMA Investing LLC 在第三季度将其在 STAAR Surgical 的持股增加了 61.4%。GAMMA Investing LLC 现在拥有 1,856 股该医疗器械供应商的股票，价值 50,000 美元，此前在上个季度增持了 706 股。最后，PNC Financial Services Group Inc.在第二季度将其在 STAAR Surgical 的持股增加了 691.0%。PNC Financial Services Group Inc.现在拥有 3,607 股该医疗器械供应商的股票，价值 61,000 美元，此前在上个季度增持了 3,151 股。对冲基金和其他机构投资者持有该公司 96.70% 的股票。</p>
<h2>关于 STAAR Surgical</h2>
<p>（获取免费报告）</p>
<p>STAAR Surgical 公司及其子公司设计、开发、制造、营销和销售用于眼睛的植入式镜片及其伴随的输送系统，以将镜片送入眼睛。该公司提供植入式 Collamer 镜片产品系列（ICLs），用于治疗视觉障碍，如近视、远视、散光和老花眼。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 STAAR Surgical</li>
<li>什么是股息？购买最佳股息股票</li>
<li>Lowe’s 与 Home Depot：哪个更能从降低利率中受益？</li>
<li>上海证券交易所综合指数是什么？</li>
<li>这五只被打压的科技股可能会迎来反弹</li>
<li>投资便士股票需要了解什么</li>
<li>Falcon Flex 推动增长，CrowdStrike 押注于 AI 安全</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ"/></p>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 STAAR Surgical 吗？</h2>
<p>在你考虑 STAAR Surgical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而 STAAR Surgical 并不在名单上。</p>
<p>虽然 STAAR Surgical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

达视光学

<p>Weiss Ratings 在最近的一份报告中 reaffirmed 对 STAAR Surgical (NASDAQ:STAA) 的 “卖出 (D)” 评级。该股票在其他分析师中获得了混合评级，Piper Sandler 将其评级上调至 “持有”，Canaccord Genuity 将其目标价提高至 28.00 美元。目前，STAAR Surgical 的共识评级为 “减持”，平均目标价为 20.67 美元。该股票开盘价为 26.50 美元，市值为 13.1 亿美元，市盈率为 -13.73。机构投资者持有该公司 96.70% 的股份</p>

<p>STAAR Surgical (NASDAQ:STAA - Get Free Report)'s stock had its &#34;sell (d)&#34; rating reissued by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.</p>
<div class="lb-trans"><p>STAAR Surgical（纳斯达克股票代码：STAA - 获取免费报告）的股票在周三发布的报告中被 Weiss Ratings 的股票研究分析师重新评定为 “卖出（d）” 评级，Weiss Ratings 报道。</p>
</div><p>Get <strong>STAAR Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>STAAR Surgical</strong> 警报：</p>
</div><ul>
<li>Top 4 Stocks With Notable Insider Buying</li>
</ul>
<div class="lb-trans"><ul>
<li>内部人士显著增持的四大股票</li>
</ul>
</div><p>STAA has been the topic of a number of other reports. Piper Sandler upgraded STAAR Surgical to a &#34;hold&#34; rating in a report on Wednesday, June 18th. Canaccord Genuity Group raised their price objective on STAAR Surgical from $20.00 to $28.00 and gave the company a &#34;hold&#34; rating in a research note on Wednesday, August 6th. Mizuho raised their price objective on STAAR Surgical from $17.00 to $18.00 and gave the company a &#34;neutral&#34; rating in a research note on Wednesday, July 16th. Finally, Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a &#34;hold&#34; rating in a research note on Thursday, August 7th. Ten research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, STAAR Surgical presently has a consensus rating of &#34;Reduce&#34; and an average target price of $20.67.</p>
<div class="lb-trans"><p>STAA 已经成为其他多份报告的主题。Piper Sandler 在 6 月 18 日的报告中将 STAAR Surgical 的评级上调至 “持有”。Canaccord Genuity Group 在 8 月 6 日的研究报告中将 STAAR Surgical 的目标价格从 20.00 美元上调至 28.00 美元，并给予该公司 “持有” 评级。Mizuho 在 7 月 16 日的研究报告中将 STAAR Surgical 的目标价格从 17.00 美元上调至 18.00 美元，并给予该公司 “中性” 评级。最后，Stifel Nicolaus 在 8 月 7 日的研究报告中设定了 STAAR Surgical 的目标价格为 28.00 美元，并给予该公司 “持有” 评级。十位研究分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，STAAR Surgical 目前的共识评级为 “减持”，平均目标价格为 20.67 美元。</p>
</div><p><strong>View Our Latest Analysis on STAAR Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们对 STAAR Surgical 的最新分析</strong></p>
</div><h2>STAAR Surgical Stock Down 0.8%</h2>
<div class="lb-trans"><h2>STAAR Surgical 股票下跌 0.8%</h2>
</div><ul>
<li>Star Surgical Shines as U.S. Outlook Improves for 2024</li>
</ul>
<div class="lb-trans"><ul>
<li>随着 2024 年美国前景改善，Star Surgical 表现亮眼</li>
</ul>
</div><p>Shares of STAA opened at $26.50 on Wednesday. STAAR Surgical has a 12-month low of $13.50 and a 12-month high of $33.28. The business's fifty day moving average is $26.83 and its 200 day moving average is $20.79. The stock has a market cap of $1.31 billion, a P/E ratio of -13.73 and a beta of 0.82.</p>
<div class="lb-trans"><p>周三，STAA 的股价开盘为 26.50 美元。STAAR Surgical 的 12 个月低点为 13.50 美元，12 个月高点为 33.28 美元。该公司的 50 日移动平均线为 26.83 美元，200 日移动平均线为 20.79 美元。该股票的市值为 13.1 亿美元，市盈率为-13.73，贝塔值为 0.82。</p>
</div><h2>Institutional Investors Weigh In On STAAR Surgical</h2>
<div class="lb-trans"><h2>机构投资者对 STAAR Surgical 的看法</h2>
</div><p>Large investors have recently added to or reduced their stakes in the company. CWM LLC increased its holdings in STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock worth $26,000 after acquiring an additional 665 shares during the last quarter. US Bancorp DE increased its holdings in STAAR Surgical by 1,693.0% in the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 1,930 shares during the last quarter. Brooklyn Investment Group increased its holdings in STAAR Surgical by 1,564.0% in the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier's stock worth $47,000 after acquiring an additional 2,518 shares during the last quarter. GAMMA Investing LLC increased its holdings in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 706 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in STAAR Surgical by 691.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,607 shares of the medical instruments supplier's stock worth $61,000 after acquiring an additional 3,151 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company's stock.</p>
<div class="lb-trans"><p>大型投资者最近增加或减少了对该公司的持股。CWM LLC 在第二季度将其在 STAAR Surgical 的持股增加了 74.1%。CWM LLC 现在拥有 1,563 股该医疗器械供应商的股票，价值 26,000 美元，此前在上个季度增持了 665 股。US Bancorp DE 在第一季度将其在 STAAR Surgical 的持股增加了 1,693.0%。US Bancorp DE 现在拥有 2,044 股该医疗器械供应商的股票，价值 36,000 美元，此前在上个季度增持了 1,930 股。Brooklyn Investment Group 在第一季度将其在 STAAR Surgical 的持股增加了 1,564.0%。Brooklyn Investment Group 现在拥有 2,679 股该医疗器械供应商的股票，价值 47,000 美元，此前在上个季度增持了 2,518 股。GAMMA Investing LLC 在第三季度将其在 STAAR Surgical 的持股增加了 61.4%。GAMMA Investing LLC 现在拥有 1,856 股该医疗器械供应商的股票，价值 50,000 美元，此前在上个季度增持了 706 股。最后，PNC Financial Services Group Inc.在第二季度将其在 STAAR Surgical 的持股增加了 691.0%。PNC Financial Services Group Inc.现在拥有 3,607 股该医疗器械供应商的股票，价值 61,000 美元，此前在上个季度增持了 3,151 股。对冲基金和其他机构投资者持有该公司 96.70% 的股票。</p>
</div><h2>About STAAR Surgical</h2>
<div class="lb-trans"><h2>关于 STAAR Surgical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.</p>
<div class="lb-trans"><p>STAAR Surgical 公司及其子公司设计、开发、制造、营销和销售用于眼睛的植入式镜片及其伴随的输送系统，以将镜片送入眼睛。该公司提供植入式 Collamer 镜片产品系列（ICLs），用于治疗视觉障碍，如近视、远视、散光和老花眼。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than STAAR Surgical</li>
<li>What Are Dividends? Buy the Best Dividend Stocks</li>
<li>Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?</li>
<li>What is the Shanghai Stock Exchange Composite Index?</li>
<li>These 5 Beaten-Down Tech Stocks Could Catch Fire Next</li>
<li>What to Know About Investing in Penny Stocks</li>
<li>Falcon Flex Drives Growth as CrowdStrike Bets on AI Security</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 STAAR Surgical</li>
<li>什么是股息？购买最佳股息股票</li>
<li>Lowe’s 与 Home Depot：哪个更能从降低利率中受益？</li>
<li>上海证券交易所综合指数是什么？</li>
<li>这五只被打压的科技股可能会迎来反弹</li>
<li>投资便士股票需要了解什么</li>
<li>Falcon Flex 推动增长，CrowdStrike 押注于 AI 安全</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RBQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=STAA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in STAAR Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 STAAR Surgical 吗？</h2>
</div><p>Before you consider STAAR Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 STAAR Surgical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STAAR Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而 STAAR Surgical 并不在名单上。</p>
</div><p>While STAAR Surgical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 STAAR Surgical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

达视光学（NASDAQ 代码：STAA）被 Weiss Ratings 评为 “卖出（D）” 评级